GlassScriptPhysician profile
Bethaney Blankenship
NPI 1396343687
$3,255.44
in general payments reported to CMS, 2019-2025
24 companies · $921 in 2025
The $921 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $816 · 2023: $910 · 2024: $607 · 2025: $921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,439.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $395.98 | 2022-2025 | |
| Shield Therapeutics INC | $360.47 | 2023-2025 | Accrufer |
| Novo Nordisk INC | $273.09 | 2022-2023 | Wegovy |
| Sage Therapeutics, LLC | $246.30 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $238.71 | 2023-2025 | Slynd, Twirla |
| Hologic Sales and Service, LLC | $233.15 | 2022-2024 | Aptima, Novasure, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $176.67 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $174.20 | 2022-2023 | |
| Stryker Corporation | $173.97 | 2025 | Clottriever Bold Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $148.78 | 2022-2025 | |
| Terumo Medical Corporation | $143.11 | 2022 | |
| Aspira Women'S Health INC | $134.39 | 2023 | Ova1 |
| Pfizer INC. | $106.18 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $103.17 | 2023-2025 | Myfembree |
| Gynesonics, INC. | $68.39 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $62.17 | 2024-2025 | Nexplanon |
| Agile Therapeutics, INC. | $59.95 | 2022 | |
| Myovant Sciences INC. | $55.94 | 2022 | |
| Bard Peripheral Vascular, INC. | $20.34 | 2024 | Arista Ah Flexitip |
| Davol INC. | $19.26 | 2025 | Arista |
| Ethicon US, LLC | $17.26 | 2024 | Enseal X1, Ethicon |
| Millicent US INC | $15.66 | 2024 | Intrarosa |
| Exact Sciences Corporation | $14.93 | 2025 | The Cologuard Plus Collection Kit |
| Avion Pharmaceuticals | $13.37 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethaney Blankenship listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.